^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
New
Title:

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib

Excerpt:
A 55-year-old woman presented with a large breast ulceration, biopsy specimen–diagnosed invasive ductal carcinoma (IDC), grade 3, ER+/PR+/HER2−…Palbociclib was switched for alpelisib (300 mg daily) with continuation of fulvestrant and zoledronic acid...Subsequent brain MRI at 3, 4, and 6 months showed stable disease without changes in measurements. This was compatible with a partial response per Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria.
DOI:
10.1200/PO.19.00403